There are 2949 resources available
LBA8_PR - Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study
Presenter: Ken Kato
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
LBA9_PR - Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study
Presenter: Ronan Kelly
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA6_PR and LBA7_PR
Presenter: Elizabeth Smyth
Session: Presidential Symposium III
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Andres Cervantes
Session: Presidential Symposium III
Resources:
Webcast
Invited Discussant LBA8_PR and LBA9_PR
Presenter: Andres Cervantes
Session: Presidential Symposium III
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Andres Cervantes
Session: Presidential Symposium III
Resources:
Webcast
Live Q&A - 28 September 2020 - 15:30-16:00
Presenter: Cristina Suarez
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Live Q&A - 28 September 2020 - 17:00-17:30
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Javier Cortés
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast
Welcome introduction and objectives and Treatment for locally advanced/metastatic cutaneous squamous cell carcinoma (CSCC)
Presenter: Chrysalyne Schmults
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast